Private Market View

Ora Biotics

Copenhagen, Denmark · Founded 2025 · Privately Held (backing)

Last price · $/share
Implied valuation
Total raised
Last round

Key facts

  • Notable investors include Rockstart, Delphinus Venture Capital.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 2 names
  • ·Watchlist + deal alerts for Ora Biotics
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Ora Biotics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About Ora Biotics

Producer of precision prebiotic fiber intended to address health challenges by making healthy choices to integrate into everyday food and drink. The company's fiber is a true precision prebiotic, targeting a keystone species in microbiome that allows attractive health benefits and claims for brand, avoids bloating or other discomforts for the consumers buying the product and is of natural origin and upcycled from a food side stream, enabling users to get low dose of fibers and improve their health conditions.

Sector
Consumer Products and Services (B2C)
HQ
Copenhagen, Denmark
Founded
2025
Employees
2
Ownership
Privately Held (backing)
PA Mark — not yet priced

Ora Biotics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Ora Biotics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Ora Biotics in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.